ArticleCurrent oncology (Toronto, Ont.)2022

Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease.

Gian Paolo Caviglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.